Anti-angiogenesis in cancer therapeutics: the magic bullet.

Oguntade, Ayodipupo S; Al-Amodi, Faez; Alrumayh, Abdullah; Alobaida, Muath; Bwalya, Mwango

Oguntade, Ayodipupo S; Al-Amodi, Faez; Alrumayh, Abdullah; Alobaida, Muath; Bwalya, Mwango.

Afiliación

Oguntade AS; Nuffield Department of Population Health, University of Oxford, Oxford, UK. ayodipupooguntade@gmail.com.
Al-Amodi F; Institute of Cardiovascular Science, University College London, London, UK. ayodipupooguntade@gmail.com.
Alrumayh A; Institute of Cardiovascular Science, University College London, London, UK.
Alobaida M; Institute of Cardiovascular Science, University College London, London, UK.
Bwalya M; Department of Basic Science, Prince Sultan Bin Abdulaziz College for Emergency Medical Services, King Saud University, Riyadh, Saudi Arabia.

J Egypt Natl Canc Inst ; 33(1): 15, 2021 Jul 02.

Article en En | MEDLINE | ID: mdl-34212275

Asunto(s)

Inhibidores de la Angiogénesis/uso terapéutico; Neoplasias/tratamiento farmacológico; Factor A de Crecimiento Endotelial Vascular/uso terapéutico; Células Endoteliales; Humanos; Inmunoterapia; Neovascularización Patológica

Palabras clave

Anti-angiogenesis; Antiangiogenics; Nanoparticle; Tumour resistance; Vascular endothelial growth factor (VEGF)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de la Angiogénesis / Factor A de Crecimiento Endotelial Vascular / Neoplasias Tipo de estudio: Screening_studies Límite: Humans Idioma: En Revista: J Egypt Natl Canc Inst Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google